CIK 0001773751
- Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,483,933
- in 10 filings, $2.5M under 10b5-1 plans
Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-15 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −35,242 | 70,484 | ||
| 2025-09-15 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −35,447 | 212,679 | ||
| 2025-09-15 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −74,529 | 745,299 | ||
| 2025-09-15 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −19,150 | 268,106 | ||
| 2025-09-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +105,199 | 222,005 | ||
| 2025-09-15 | Okupe Oluyemi Chief Financial Officer | Shares withheld for taxes 10b5-1 | −58,021 | $53.96 | $3.1M | 163,984 |
| 2025-09-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +110,000 | $5.01 | $551K | 273,984 |
| 2025-09-15 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −117,792 | $55.25 | $6.5M | 156,192 |
| 2025-09-15 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −27,208 | $55.79 | $1.5M | 128,984 |
| 2025-09-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −52,395 | 104,791 | ||
| 2025-09-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −18,334 | 110,007 | ||
| 2025-09-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −22,988 | 229,881 | ||
| 2025-09-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Restricted Stock Unit 10b5-1 | −11,482 | 160,755 | ||
| 2025-09-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −110,000 | 239,784 | ||
| 2025-09-15 | Schultz Kare Director | Exercise or conversion | +6,623 | 15,741 | ||
| 2025-09-15 | Schultz Kare Director | Exercise or conversion · Restricted Stock Unit | −6,623 | 13,247 | ||
| 2025-08-26 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +11,581 | $5.01 | $58K | 128,387 |
| 2025-08-26 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −11,581 | $43.69 | $506K | 116,806 |
| 2025-08-26 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −11,581 | 349,784 | ||
| 2025-08-25 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −2,571 | $44.53 | $114K | 150,450 |
Page 25 of 37 · 739 trades